Press Releases Year All Years 2021 2020 2019 2018 2017 2016 2015 2014 Category All Releases Financial Releases Recro Pharma Presents Phase III Bunionectomy Clinical Data for IV Meloxicam at the American Pain Society 36th Annual Scientific Meeting May 18, 2017 8:00am EDT Recro Pharma to Present Phase III Bunionectomy Clinical Data for IV Meloxicam at the American Pain Society 36th Annual Scientific Meeting May 15, 2017 7:00am EDT Recro Pharma Reports First Quarter 2017 Financial Results May 11, 2017 7:00am EDT Recro Pharma Announces Successful Top-Line Results from Phase III Safety Study of IV Meloxicam May 09, 2017 7:00am EDT Recro Pharma to Present at the 16th Annual Needham Healthcare Conference Mar 29, 2017 7:00am EDT Recro Pharma to Present at the Oppenheimer 27th Annual Healthcare Conference Mar 16, 2017 7:00am EDT Recro Pharma Reports Year End 2016 Financial Results Mar 06, 2017 4:05pm EST Recro Pharma Appoints Bryan Reasons to Its Board of Directors Mar 06, 2017 7:00am EST Recro Pharma to Present at Upcoming Investor Conferences Mar 02, 2017 7:00am EST Recro Pharma Completes Enrollment in Phase III Safety Study of IV Meloxicam Feb 27, 2017 7:00am EST Prev 1... 6 7 8 9 10 11 12 13 14 15 ...17 Next
Recro Pharma Presents Phase III Bunionectomy Clinical Data for IV Meloxicam at the American Pain Society 36th Annual Scientific Meeting May 18, 2017 8:00am EDT
Recro Pharma to Present Phase III Bunionectomy Clinical Data for IV Meloxicam at the American Pain Society 36th Annual Scientific Meeting May 15, 2017 7:00am EDT
Recro Pharma Announces Successful Top-Line Results from Phase III Safety Study of IV Meloxicam May 09, 2017 7:00am EDT